- Home
- CLDX vs GRDN Comparison
CLDX vs GRDN Comparison
Compare CLDX & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- GRDN
- Stock Information
- Founded
- CLDX 1983
- GRDN 2004
- Country
- CLDX United States
- GRDN United States
- Employees
- CLDX N/A
- GRDN N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- GRDN Retail-Drug Stores and Proprietary Stores
- Sector
- CLDX Health Care
- GRDN Consumer Staples
- Exchange
- CLDX Nasdaq
- GRDN Nasdaq
- Market Cap
- CLDX 1.6B
- GRDN 1.4B
- IPO Year
- CLDX 2008
- GRDN 2024
- Fundamental
- Price
- CLDX $23.78
- GRDN $20.67
- Analyst Decision
- CLDX Buy
- GRDN Strong Buy
- Analyst Count
- CLDX 7
- GRDN 2
- Target Price
- CLDX $64.83
- GRDN $22.50
- AVG Volume (30 Days)
- CLDX 1.1M
- GRDN 229.7K
- Earning Date
- CLDX 02-24-2025
- GRDN 02-15-2025
- Dividend Yield
- CLDX N/A
- GRDN N/A
- EPS Growth
- CLDX N/A
- GRDN N/A
- EPS
- CLDX N/A
- GRDN N/A
- Revenue
- CLDX $9,976,000.00
- GRDN $1,170,907,000.00
- Revenue This Year
- CLDX N/A
- GRDN $18.05
- Revenue Next Year
- CLDX N/A
- GRDN $9.55
- P/E Ratio
- CLDX N/A
- GRDN N/A
- Revenue Growth
- CLDX 128.55
- GRDN 16.86
- 52 Week Low
- CLDX $22.17
- GRDN $14.16
- 52 Week High
- CLDX $53.18
- GRDN $25.74
- Technical
- Relative Strength Index (RSI)
- CLDX 41.99
- GRDN N/A
- Support Level
- CLDX $22.17
- GRDN N/A
- Resistance Level
- CLDX $29.05
- GRDN N/A
- Average True Range (ATR)
- CLDX 1.57
- GRDN 0.00
- MACD
- CLDX -0.26
- GRDN 0.00
- Stochastic Oscillator
- CLDX 23.40
- GRDN 0.00
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.